| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Solesence expects at least $65M in shipped and on-hand orders by year-end, while pointing to potential >20% EBITDA longer term | 12 | Seeking Alpha | ||
| 12.11. | Solésence, Inc.: Solésence Reports Record Third Quarter 2026 Financial Results | 4 | GlobeNewswire (USA) | ||
| 12.11. | SOLESENCE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.11. | SOLESENCE, INC. - 8-K, Current Report | - | SEC Filings | ||
| 10.11. | SOLESENCE, INC. - 10-Q/A, Quarterly Report | - | SEC Filings | ||
| 10.11. | SOLESENCE, INC. - 10-K/A, Annual Report | - | SEC Filings | ||
| 02.10. | SOLESENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 11.09. | Solésence Beauty Science win the inaugural Cosmetics Business Innovation Awards for Contract Manufacturing Partner of the Year | 13 | Cosmetics Business | ||
| SOLESENCE Aktie jetzt für 0€ handeln | |||||
| 20.08. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Solesence Reports Q2 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 19.08. | Solesence reports Q2 results | 1 | Seeking Alpha | ||
| 19.08. | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | 761 | GlobeNewswire (Europe) | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| 19.08. | SOLESENCE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.07. | Solésence, Inc.: Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp | 4 | GlobeNewswire (USA) | ||
| 10.07. | SOLESENCE, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.06. | Solésence, Inc.: Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards | 7 | GlobeNewswire (USA) | ||
| 31.03. | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | 1.123 | GlobeNewswire (Europe) | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 14,500 | -3,97 % | EQS-News: Formycon AG: Formycon verdoppelt Neunmonatsumsatz und treibt Umsetzung der Wachstumsstrategie FYB4Growth konsequent voran | EQS-News: Formycon AG
/ Schlagwort(e): 9-Monatszahlen
Formycon verdoppelt Neunmonatsumsatz und treibt Umsetzung der Wachstumsstrategie FYB4Growth konsequent voran
12.11.2026... ► Artikel lesen | |
| RIBER | 5,900 | 0,00 % | Riber Reports Improved Results For The First Half Of 2026 | RIBER REPORTS IMPROVED RESULTS FOR THE FIRST HALF OF 2026 Revenues of €12.7m (+19%) and gross margin of €5.1m (+31%), representing 39.8% of revenuesPositive net income of €0.2m, compared with -€0.8m... ► Artikel lesen | |
| ONTO INNOVATION | 189,20 | +3,33 % | Onto Innovation Inc.: Onto Innovation to Participate in Upcoming Investor Events | Onto Innovation Inc. (NYSE: ONTO) ("Onto Innovation," "Onto," or the "Company") today announced that its senior management team will participate in the following upcoming investor events:
RBC... ► Artikel lesen | |
| KOPIN | 2,749 | +1,44 % | Stifel bekräftigt Kaufempfehlung für Kopin nach starkem Quartalsergebnis | ||
| GOMSPACE | 1,225 | -1,13 % | GomSpace Group AB: GomSpace reports continued profitable growth in Q3 and narrows full year guidance | GomSpace reports continued profitable growth in Q3 and narrows full year guidance
GomSpace delivers revenue growth with a 14% EBITDA margin in Q3 and sets 2030 financial targets of SEK 1.6 billion... ► Artikel lesen | |
| NANOFORM FINLAND | 0,773 | -2,64 % | Nanoform Finland Oyj: Nanoform Q2 2026 - Positive feedback from scientific advice meeting in the UK, significantly improved cash flow and discussions with CDMOs on sterile GMP for our Biologics technology initiated | Nanoform Finland Plc | Company Release | August 20, 2026 at 08:10:00 EEST
Nanoenzalutamide project continues with the communicated multitrack strategy supported by all partners. After a positive scientific... ► Artikel lesen | |
| GAUZY | 4,770 | -5,36 % | GAUZY LTD: Gauzy Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal | TEL AVIV, Israel, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced receipt of a delisting... ► Artikel lesen | |
| ZENTEK | 0,362 | +5,23 % | Zentek Ltd.: Zentek Q2 Fiscal 2027 Results News Release | Zentek Strengthens Its Balance Sheet, Ends Second Quarter with $13.6 Million in CashWorking capital of $11.3 million at September 30, 2026, compared with a deficit of $1.3 million at March 31, 2026Guelph... ► Artikel lesen | |
| VEECO INSTRUMENTS | 34,060 | 0,00 % | Veeco Instruments Inc.: Veeco Announces Upcoming Investor Events | ||
| OBDUCAT | 0,033 | +26,92 % | NGM MARKET NOTICE: #26-72 Decision by the Disciplinary Committee regarding Obducat AB (publ) | ||
| ACACIA RESEARCH | 3,620 | -1,09 % | ACACIA RESEARCH CORP - 10-K/A, Annual Report | ||
| NVE | 71,50 | 0,00 % | Dividendenbekanntmachungen (02.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABM INDUSTRIES INC US0009571003 0,29 USD EUR ACUITY INC US00508Y1029 0,2 USD EUR AMERISERV FINANCIAL INC US03074A1025 0,03... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,298 | -0,67 % | ADVANCE ZINCTEK LIMITED: Proposed Capital Reduction of 3 Cents | ||
| LAMPETIA | 0,105 | 0,00 % | EQS-Adhoc: Lampetia AG: Verkauf der Lampetia Investments Engineering Ltd geplant | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Mergers und Acquisitions / Verkauf von Unternehmensteilen
Lampetia AG: Verkauf der Lampetia Investments Engineering Ltd geplant
06.11.2026... ► Artikel lesen | |
| DOTZ NANO | 0,005 | -16,67 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |